Market Research Logo

Xtant Medical Holdings Inc (XTNT) - Product Pipeline Analysis, 2017 Update

Summary

Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings, Inc. is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowrap, orbitalwrap HD, facet stabilization, milled cervical spacers, traditional allografts, hMatrix ADM, hMatrix PR ADM, and sports medicine. It utilizes sterile technology for manufacturing bacterin products. The company offers its products for the treatment of degenerative, traumatic, and deformity conditions for orthopedic and neurological applications. It operates in Louisiana, Maryland, Oregon, Illinois, Delaware, California, Florida, and New York. Xtant Medical is headquartered in Belgrade, Montana, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Xtant Medical Holdings Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Xtant Medical Holdings Inc Company Overview
Xtant Medical Holdings Inc Company Snapshot
Xtant Medical Holdings Inc Pipeline Products and Ongoing Clinical Trials Overview
Xtant Medical Holdings Inc – Pipeline Analysis Overview
Xtant Medical Holdings Inc - Key Facts
Xtant Medical Holdings Inc - Major Products and Services
Xtant Medical Holdings Inc Pipeline Products by Development Stage
Xtant Medical Holdings Inc Pipeline Products Overview
Anti-Microbial Coated GenerOs CF
Anti-Microbial Coated GenerOs CF Product Overview
Anti-Microbial Coated GenerOs SB Generator
Anti-Microbial Coated GenerOs SB Generator Product Overview
Disk Augmentation System
Disk Augmentation System Product Overview
Interbody Fusion Device
Interbody Fusion Device Product Overview
Lumbar Dynamic Posterior Stabilization Device
Lumbar Dynamic Posterior Stabilization Device Product Overview
Monetite Granules Based Bone Graft
Monetite Granules Based Bone Graft Product Overview
Next Generation Demineralized Bone Matrix Allograft
Next Generation Demineralized Bone Matrix Allograft Product Overview
OsteoSponge SC - Cartilage Re-generation Scaffold
OsteoSponge SC - Cartilage Re-generation Scaffold Product Overview
Xsert Lumbar Expandable Interbody System
Xsert Lumbar Expandable Interbody System Product Overview
XTANT 3D Printer
XTANT 3D Printer Product Overview
Xtant Medical Holdings Inc - Key Competitors
Xtant Medical Holdings Inc - Key Employees
Xtant Medical Holdings Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Xtant Medical Holdings Inc, Recent Developments
May 09, 2017: Xtant Medical Reports First Quarter Revenue of $22.1 million, 5% Growth Compared to the Prior Year Period
Mar 09, 2017: Xtant Medical Reports Record Fourth Quarter Revenue of $24.5 million, 10% Growth Compared to Prior Year Period
Feb 22, 2017: Xtant Medical Announces Appointment of Carl O'Connell to Permanent CEO
Jan 23, 2017: Xtant Medical CEO Dan Goldberger announces resignation
Jan 11, 2017: XTNT Announces Preliminary Fourth Quarter and Full Year 2016 Revenue & Adjusted EBITDA
Nov 23, 2016: Xtant Medical Receives FDA Clearance for the Xsert Lumbar Expandable Interbody System
Nov 15, 2016: Xtant Medical Receives FDA Clearance to Use Allografts in the Stand-Alone Irix-C Cervical Cage
Nov 14, 2016: Xtant Medical Announces First Surgical Cases of Xspan Laminoplasty Fixation System
Nov 07, 2016: Xtant Medical Holdings Reports Record Third Quarter 2016 Results
Nov 01, 2016: Xtant Medical Receives Approval of Compliance Plan from NYSE MKT
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Xtant Medical Holdings Inc Pipeline Products and Ongoing Clinical Trials Overview
Xtant Medical Holdings Inc Pipeline Products by Equipment Type
Xtant Medical Holdings Inc Pipeline Products by Indication
Xtant Medical Holdings Inc, Key Facts
Xtant Medical Holdings Inc, Major Products and Services
Xtant Medical Holdings Inc Number of Pipeline Products by Development Stage
Xtant Medical Holdings Inc Pipeline Products Summary by Development Stage
Anti-Microbial Coated GenerOs CF - Product Status
Anti-Microbial Coated GenerOs CF - Product Description
Anti-Microbial Coated GenerOs SB Generator - Product Status
Anti-Microbial Coated GenerOs SB Generator - Product Description
Disk Augmentation System - Product Status
Disk Augmentation System - Product Description
Interbody Fusion Device - Product Status
Interbody Fusion Device - Product Description
Lumbar Dynamic Posterior Stabilization Device - Product Status
Lumbar Dynamic Posterior Stabilization Device - Product Description
Monetite Granules Based Bone Graft - Product Status
Monetite Granules Based Bone Graft - Product Description
Next Generation Demineralized Bone Matrix Allograft - Product Status
Next Generation Demineralized Bone Matrix Allograft - Product Description
OsteoSponge SC - Cartilage Re-generation Scaffold - Product Status
OsteoSponge SC - Cartilage Re-generation Scaffold - Product Description
Xsert Lumbar Expandable Interbody System - Product Status
Xsert Lumbar Expandable Interbody System - Product Description
XTANT 3D Printer - Product Status
XTANT 3D Printer - Product Description
Xtant Medical Holdings Inc, Key Employees
Xtant Medical Holdings Inc, Subsidiaries
Glossary
List of Figures
Xtant Medical Holdings Inc Pipeline Products by Equipment Type
Xtant Medical Holdings Inc Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report